Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Recall #: D-0167-2017
Affected scope: 6,333,669 tablets
Initiated: October 28, 2016

Compiled from official public sources by the publisher. · Updated September 2026

Nationwide Laboratories, LLC recalled Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactu… - a moderate-severity action.

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactu… was recalled by Nationwide Laboratories, LLC in December 7, 2016. Reason: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.. Check the official notice for the remedy. Verify recall #D-0167-2017 with the FDA Drug before acting.

The recall

Nationwide Laboratories, LLC issued this moderate-severity FDA Drug recall-CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures..

Moderate
severity level: Class II
classification: December 7, 2016
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0167-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.

Reason for recall

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-0167-2017
Date reported	December 7, 2016
Date initiated	October 28, 2016
Recalling firm	Nationwide Laboratories, LLC
Firm location	Iselin, NJ
Affected scope	6,333,669 tablets
Distribution	Nationwide in USA and Puerto Rico

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0167-2017) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.. Recalled by Nationwide Laboratories, LLC. Units affected: 6,333,669 tablets.

Why was this product recalled? ▼

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on December 7, 2016. Severity: Moderate. Recall number: D-0167-2017.

Where was the recalled product distributed? ▼

Distribution: Nationwide in USA and Puerto Rico.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Schurman Retail Group Recalls Gift Boxes … 2016-12-07 Playworld Recalls Stainless Steel Playgro… 2016-12-07 Travoprost Ophthalmic Solution USP, 0.004… 2016-12-07 Hyolev MB URINARY ANTISEPTIC Tablets, Eac… 2016-12-07

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

UROLET MB URINARY ANTISEPTIC, ANTISPASMOD… 2016-12-07 URAMIT MB URINARY ANTISEPTIC Capsules, Ea… 2016-12-07 UROPHEN MB URINARY ANTISEPTIC Tablets, Ea… 2016-12-07 AZUPHEN MB URINARY ANTISEPTIC Capsules, E… 2016-12-07

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported December 7, 2016. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026